MedTrace Logo

Acceptability of Self-Led Mindfulness-Based Intervention

NCT05115175 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-08-01

No results posted yet for this study

Summary

This study had two primary aims. First, the investigators examined the associations between mindfulness and diabetes-related outcomes. It was hypothesized that at baseline, increased mindfulness would be associated with decreased diabetes distress and more optimal glycemic levels and that all three variables would share similar associations with related constructs including greater self-compassion, lower general stress, better psychosocial health, increased diabetes treatment engagement, and greater diabetes-related quality of life. The association between specific aspects of dispositional mindfulness and diabetes distress was also explored. Second, the investigators examined the acceptability, feasibility, and potential utility of self-led MBSR intervention. It was hypothesized that participation in a self-led MBSR intervention would be feasible and acceptable, evidenced by treatment attrition and participant feedback. It was also hypothesized that participants who received the self-led Mindfulness-based stress reduction (MBSR) intervention would experience increased mindfulness and decreased diabetes distress compared to a waitlist control group.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

BEHAVIORAL

Mindfulness-Based Stress Reduction

Participants engaged in meditation and self-led exercises to help them understand and cope with stress.

Sponsors & Collaborators

  • AlterMed Research foundation

    collaborator UNKNOWN

  • University of Nevada, Reno

    lead OTHER

Principal Investigators

  • Holly Hazlett-Stevens, Ph.D. · University of Nevada, Reno

  • Amy Hughes Lansing, Ph.D. · University of Nevada, Reno

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-14
Primary Completion
2020-04-17
Completion
2020-07-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115175 on ClinicalTrials.gov